Loading
institutionsInstitution
Shanghai Pulmonary Hospital
Shanghai Pulmonary Hospital is a lung-only hospital with one of the largest thoracic surgery volumes anywhere; Caicun Zhou's medical oncology department was the Chinese lead site for the first-generation EGFR inhibitor trials and for camrelizumab, sintilimab and tislelizumab combinations in lung cancer.
Also called: Shanghai Pulmonary Hospital, Tongji University上海市肺科医院
Overview
Shanghai Pulmonary Hospital, affiliated to Tongji University, is a national clinical research centre for lung disease and one of the highest-volume thoracic surgery centres anywhere, known for uniportal and robotic lobectomy and for large early-stage screening cohorts. Caicun Zhou's Department of Medical Oncology has been the Chinese lead site for first-generation EGFR inhibitor trials, camrelizumab, sintilimab and tislelizumab combinations, and ADC studies in NSCLC. The hospital publishes extensively on ground-glass nodules, minimally invasive surgery and the molecular epidemiology of lung cancer in never-smokers.
Location
Shanghai, CN
Type
hospital · Tongji University
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#281 · 24 points (0 Newsweek + 0 NCI + 24 from 12 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Shanghai Pulmonary Hospital, including child institutions. 464 works · 6,795 citations · 75% open access · 17% clinical trials · 1% reviews.
Oncology works per year
1012022
982023
1012024
992025
652026
Most works
- Caicun Zhou45 works
- Chunxia Su34 works
- Shengxiang Ren30 works
- Peng Zhang27 works
- Caicun Zhou21 works
- Ying Cheng20 works
- Gening Jiang17 works
- Lele Zhang17 works
- Huansha Yu16 works
- Fengying Wu15 works
Most cited
- Lung cancer medical oncology trials
- Thoracic surgery
- Lung nodule management
Similar pages
- CompanyOnc.AI
Shares CT (computed tomography), PD-1, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- CompanyXACT Robotics
Shares CT (computed tomography), Robotic & minimally invasive surgery, Non-small-cell lung cancer.
- InstitutionShanghai Chest Hospital
Shares ALK, Robotic & minimally invasive surgery, EGFR, Small-cell lung cancer.
- CollectionLUNGevity Foundation (and GO2 for Lung Cancer)
Shares ALK, EGFR, Small-cell lung cancer, Non-small-cell lung cancer.
- TermPneumonitis
Shares CT (computed tomography), Small-cell lung cancer, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- PairingSequence: targeted therapy before immunotherapy in driver-positive NSCLC
Shares ALK, EGFR, Small-molecule kinase inhibitors, Immune checkpoint inhibitors.
- InstitutionInternational Association for the Study of Lung Cancer
Shares Caicun Zhou, CT (computed tomography), Small-cell lung cancer, Small-molecule kinase inhibitors.
- TrialALKOVE-1
Shares ALK, Small-molecule kinase inhibitors, Non-small-cell lung cancer.